Publication | Open Access

Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune-checkpoint inhibitors: A United States population-level analysis

Cancer EpidemiologyImmune-checkpoint InhibitorsMedicineImmunologyClinical EpidemiologyClinical DermatologyImmune Checkpoint InhibitorCutaneous ToxicitiesDermatologyPublic HealthImmunotherapyOncologyRisk FactorsCancer ResearchSkin Cancer